Vincera Pharma Inc (VINC)
0.6300 x 5 0.6500 x 1
Post-market by (Cboe BZX)
0.6480 +0.0280 (+4.52%) 03/21/25 [NASDAQ]
0.6300 x 5 0.6500 x 1
Post-market 0.6230 -0.0250 (-3.86%) 18:47 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 42,609 | 71,191 | 62,656 | 10,714 | 45 |
| Operating Income | -42,609 | -71,191 | -62,656 | -10,714 | -45 |
| Other Income | 2,452 | 8,207 | 23,350 | -5,906 | 0 |
| Pre-tax Income | -40,157 | -62,984 | -39,306 | -16,620 | -45 |
| Net Income Continuous | -40,157 | -62,984 | -39,306 | -16,620 | -45 |
| Net Income | $-40,157 | $-62,984 | $-39,306 | $-16,620 | $-45 |
| EPS Basic Total Ops | -37.80 | -60.00 | -45.80 | -63.20 | -0.20 |
| EPS Basic Continuous Ops | -37.72 | -59.90 | -45.77 | -63.29 | -0.20 |
| EPS Diluted Total Ops | -37.80 | -60.00 | -45.80 | -63.20 | -0.20 |
| EPS Diluted Continuous Ops | -37.72 | -59.90 | -45.77 | -63.29 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -37.80 | -62.20 | -73.00 | -40.80 | N/A |
| EBITDA(a) | $-42,324 | $-70,544 | $-62,316 | $-10,694 | $-45 |